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Migraine is a common and disabling neurological disease of unknown origin characterized by a remarkable clinical
variability. It shows strong familial aggregation, suggesting that genetic factors are involved in its pathogenesis.
Different approaches have been used to elucidate this hereditary component, but a unique transmission model and
causative gene(s) have not yet been identified. We report clinical and molecular data from a large Italian pedigree
in which migraine without aura (MO) segregates as an autosomal dominant trait. After exclusion of any association
between MO and the known familial hemiplegic migraine and migraine with aura loci, we performed a genomewide
linkage analysis using 482 polymorphic microsatellite markers. We obtained significant evidence of linkage between
the MO phenotype and the marker D14S978 on 14q22.1 (maximum two-point LOD score of 3.70, at a recom-
bination fraction of 0.01). Multipoint parametric analysis (maximum LOD score of 5.25 between markers D14S976
and D14S978) and haplotype construction showed strong evidence of linkage in a region of 10 cM flanked by
markers D14S1027 and D14S980 on chromosome 14q21.2-q22.3. These results indicate the first evidence of a
genetic locus associated with MO on chromosome 14.
Migraine (MIM 157300) is a complex and heterogeneous
disease characterized by recurrent attacks of headache
associated with autonomic and neurological symptoms,
that affects ∼12% of the general population (Stewart et
al. 1992). Diagnosis is based on clinical criteria, since
biochemical or instrumental tests are not available (Head-
ache Classification Committee of the International Head-
ache Society [HCCIHS] 1988). Two primary types of mi-
graine can be distinguished: migraine without aura
(MO) and migraine with aura (MA).MO, the most com-
mon form of migraine, is characterized by unilateral pul-
sating headache of moderate to severe intensity, lasting
4–72 h. The attacks are associated with nausea, vom-
iting, and photo- and phonophobia and are aggravated
by physical activity. In MA, headache attacks are pre-
ceded by transient focal neurological aura symptoms,
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which are usually visual. Frequency, duration, and se-
verity of the attacks vary substantially among patients
and also in the same patients. Moreover, these two
forms of migraine can co-occur in up to 33% of mig-
raineurs (Russell et al. 1995), but usually one type of
attack prevails.
The etiopathogenesis of migraine remains largely un-
known. Neurophysiological and neurofunctional studies
support a primary neuronal theory, according to which
a neuronal hyperexcitability is the biological basis for
susceptibility to migraine (Hargreaves and Shepheard
1999). Neuronal instability should be responsible for
neuroelectric (Goadsby and Edvinsson 1993; Lauritzen
et al. 1994) and metabolic events (Goadsby et al. 1990)
leading to migraine attack. Familial clustering suggests
that migraine has a significant genetic component, but
the mode of inheritance remains unclear (Mochi et al.
1993; Russell and Olesen 1993). Family-, twin-, and
population-based studies strongly suggest that the two
types of migraine are genetically determined, most likely
with a multifactorial mode of inheritance (Honkasalo et
al. 1995; Stewart et al. 1997; Gervil et al. 1999; Ulrich
et al. 1999). However, in some families, a Mendelian
pattern of inheritance cannot be excluded (Russell and
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Olesen 1995). At present, the only nosologic entity ge-
netically characterized is familial hemiplegic migraine
(FHM) (FHM1 [MIM 141500]), a rare autosomal dom-
inantly inherited subtype of MA in which hemiplegia is
the principal aura feature (HCCIHS 1988). It is consid-
ered a genetically heterogeneous disorder; half of the
known families with FHM have been associated with
mutations in the brain-specific P/Q type calcium channel
alpha subunit (CACNA1A) located on 19p13 chromo-
some (MIM 601011) (Joutel et al. 1993; Ophoff et al.
1996; Ducros et al. 2001), and additional FHM linkage
loci have been reported on chromosomes 1q21-q23
(FHM2 [MIM602481]) (Ducros et al. 1997) and on 1q31
(Gardner et al. 1997). FHM can be considered part of
the migraine spectrum and, thus, it has been used as a
model to study the complex genetics of the common forms
of migraine. Nevertheless, the role of 19p FHM locus in
MO and MA is still debated (May et al. 1995; Hovatta
et al. 1998; Nyholt et al. 1998). In familial typical mi-
graine, linkage to 1q31 FHM locus (Lea et al. 2002)
and to chromosome Xq24-q28 was recently established
(MFTS [MIM 300125]) (Nyholt et al. 2000). Moreover,
a new locus on chromosome 19p13, distinct from the
CACNA1A gene, was found to be linked to MA (Jones
et al. 2001), and a susceptibility locus for MA was iden-
tified on chromosome 4q24 (MGAU [MIM 300125]) by
Wessman et al. (2002). Genetic association studies have
suggested linkage between different genetic loci and ei-
ther MO orMA (Pardo et al. 1995; Peroutka et al. 1997;
Ogilvie et al. 1998; Lea et al. 2000; McCarthy et al.
2001, Tzourio et al. 2001), but the results of these stud-
ies often remain controversial and unconfirmed.
Identification of genes predisposing to migraine has
been complicated by clinical and genetic heterogeneity
of the disease. However, studies of large pedigrees with
a clear pattern of inheritance might be extremely useful
in identifying genes involved in migraine pathogenesis.
Here, we describe a large four-generation Italian fam-
ily, originating from a restricted geographical area of
northern Italy, in which MO appears to segregate as an
autosomal dominant trait (fig. 1). After exclusion of any
association between MO and the known FHM and MA
loci, we performed a genomewide scan of the 22 auto-
somes to identify the putative genetic locus associated
with MO.
The propositus (III:10), a 49-year-old man, was the
fourth child of nonconsanguineous parents. Since his
adolescence, he complained of migraine attacks occur-
ring once per wk. The attacks were characterized by
severe pulsating unilateral headache lasting 12 h, ac-
companied by nausea and photo- and phonophobia.
Neither premonitory symptoms nor triggering factors
typical for migraine nor neurological aura was reported.
The common antimigraine agents resulted only in a par-
tial and brief relief of pain, and prophylactic headache
medication (propanolol and amitriptyline) had low ef-
ficacy. General examination was normal; neurological
examination disclosed the presence of diffuse brisk deep
tendon reflexes without asymmetry. Electroencephalo-
gram (EEG) and brain CT scan were within normal lim-
its. Family history revealed that other family members
suffered recurrent migraine attacks. A total of 33 sub-
jects (27 family members and 6 spouses) were evaluated
by a certified neurologist. Clinical evaluation included
extensive history and physical and neurological exam-
ination. EEG and CT scan were performed in five in-
dividuals (II:6, III:5, III:7, III:12, and III:16). When
HCCIHS (1988) criteria were used for diagnosing
MO, 22 subjects were categorized as affected and 11
as unaffected (fig. 1). Among the 22 MO subjects,
clinical features were almost homogeneous; attacks
were characterized by moderate–severe pulsating uni-
lateral headache lasting from a few hours to some
days and accompanied by nausea and/or photo- and
phonophobia. Migraine attack frequency was variable,
from 1–2 attacks per mo to 2–3 attacks per wk. Two
subjects (III:5 and III:16) occasionally experienced mi-
graine attacks preceded by visual aura lasting a few
minutes in addition to high frequency (11 per wk) of
MO attacks. In particular, subject III:5, whowas affected
with borderline hypertension, experienced two episodes
of migraine with visual aura; individual III:16 presented
only one attack of migraine with visual aura. We think
that the isolated occurrence of MA attacks does not
change the diagnosis of MO in these subjects. Disease
onset was during childhood or adolescence in all indi-
viduals. All subjects were normal at the physical ex-
amination, although neurological examination disclosed
the presence of a diffuse hyperactivity of the muscle
stretch reflexes in eight affected individuals (II:6, III:5,
III:7, III:8, III:10, III:12, IV:5, and IV:9). EEG and brain
CT scan were within normal limits in the examined
subjects.
We obtained informed consent from 21 subjects af-
fected with MO and 3 unaffected subjects (1 family mem-
ber, IV:7, and 2 spouses, II:5 and III:6), on whom we
performed molecular analyses. Venous blood samples
were used to extract genomic DNA and to establish per-
manent lymphoblastoid cell lines according to standard
techniques.
First, we selected microsatellite markers from the pu-
tative candidate regions for FHM and MA on chromo-
somes 19p13, 1q21-23, 1q31, and 4q24. For these ana-
lyzed markers, we obtained two-point LOD score values
!2 at a recombination fraction (v) of 0.0 (data not shown).
To identify the genetic locus associated withMO in this
large pedigree, we performed a genomewide search using
382 fluorescently labeled microsatellites from the ABI
PRISM Linkage Mapping Set, version 2 (LMS2, Applied
Biosystems). To improve the coverage of the whole ge-
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Figure 1 MO family pedigree. Individuals available for typing are indicated by the generated genotype data. The disease haplotype for
MO is indicated by the blackened bar. Blackened symbols denote affected individuals; unblackened symbols denote unaffected individuals. The
arrow indicates the propositus; the asterisks indicate key recombinants (III:4 and IV:10), who determine the critical interval to be 10 cM, flanked
by markers D14S1027 and D14S980.
nome, we used another 100microsatellitemarkers chosen
from the ABI PRISM Linkage Mapping set Version 5
(LMS5, Applied Biosystems). Using these 482 markers,
we obtained a genome screening with a resolution of ∼5
cM. PCR reactions were performed according to the con-
dition described in the LMS2 user’s manual. PCR prod-
ucts were run on a 7% denaturing polyacrylamide gel
using an ABI373 automatic DNA sequencer, and the in-
strument’s output was analyzed using GENESCAN 672
1.2 andGENOTYPER1.1 software applications (Applied
Biosystems). Parametric LOD score for 482 markers used
in the genomewide linkage analysis was calculated using
the affected-only strategy, because it is the fittest method
for complex diseases such as MO. Two-point LOD score
values were calculated using the MLINK program of the
LINKAGE package version 5.2 (Lathrop et al. 1984).
Linkage analysis was performed assuming a dominant
model with a complete penetrance, a phenocopy rate of
0.7% (Hovatta et al. 1994) and a disease allele frequency
of 12% (Stewart et al. 1992). To assess the statistical
significance of linkage, we considered a threshold value
of 3.3, as suggested by Lander and Kruglyak (1995).
The highest two-point LOD score values were obtained
for marker D14S288 ( at ) andZp 2.76 vp 0.10
D14S276 ( at ) on chromosome14q21Zp 2.44 vp 0.05
(table 1). No other chromosomal regions presented sta-
tistical evidence of linkage. That region was further an-
alyzed selecting eight additional unlabeled markers
(D14S75, D14S1048, D14S1027, D14S1068, D14S976,
D14S978, D14S139, and D14S980) according to the
UCSC Human Genome Project Working Draft Database.
Three markers gave a LOD score 13.3, with a maximum
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Table 1
Two-Point LOD Scores for Migraine without Aura (MO)
and Microsatellite Markers on Chromosome 14q
MARKER
LOD AT v p
.00 .01 .05 .10 .20 .30 .40
D14S75 1.42 .70 .17 .47 .54 .35 .11
D14S1048 2.45 1.24 .34 1.00 1.29 1.05 .56
D14S288 1.76 2.20 2.70 2.76 2.38 1.70 .82
D14S1027 2.47 2.54 2.61 2.51 2.04 1.39 .63
D14S1068 3.56 3.61 3.59 3.38 2.73 1.89 .90
D14S976 3.53 3.57 3.54 3.32 2.65 1.81 .85
D14S978 3.65 3.70 3.68 3.46 2.79 1.93 .92
D14S139 2.76 2.82 2.85 2.70 2.19 1.50 .69
D14S276 2.31 2.38 2.44 2.33 1.89 1.29 .58
D14S980 1.51 1.94 2.45 2.52 2.17 1.54 .73
two-point LOD score value of 3.70 at forvp 0.01
marker D14S978 (table 1).
Multipoint analysis was performed by the FASTMAP
program (Curtis et al. 1993), using intermarker genetic
distances based on the sex-averaged distances reported
by the Genetic Location Database. Multipoint linkage
LOD score provided strong evidence of linkage between
markers D14S1027 and D14S980, with a peak of 5.25
between D14S976 and D14S978 (fig. 2). The most likely
haplotype cosegregating with the disease is displayed in
figure 1 along with the pedigree. The upper and lower
limits of the critical region were established by the re-
combination events occurring in individual IV:10 (be-
tween markers D14S1027 and D14S68) and individual
III:4 (between markers D14S276 and D14S980) (fig. 1).
Our results provide strong evidence of an MO sus-
ceptibility locus on chromosome 14q21.2-14q22.3
within a 10-cM interval flanked by markers D14S1027
and D14S980.
Statistically significant evidence of linkage was ob-
tained with a parametric two-point linkage analysis and
was supported by multipoint analyses. We chose to per-
form a parametric linkage analysis, since, in this family,
MO segregates as an autosomal trait and presents with
homogenous clinical features; therefore, it was plausible
that a unique genetic defect contributes to risk of MO.
Among the affected individuals, only III:7 does not share
the affected haplotype and still presents with MO. Con-
sidering the high prevalence of migraine in the popu-
lation and its complex etiology, subject III:7 may rep-
resent a phenocopy.
According to the UCSCHumanGenome ProjectWork-
ing Draft database, the flanking markers D14S1027 and
D14S980 span a 12-Mb candidate region, which contains
45 known genes and 1100 predicted genes. To better re-
fine the disease haplotype, SNPs in the known genes can
be used. Moreover, the collection of other affected family
members can be useful to identify more recombinations
to further narrow the region. Meanwhile, interesting
candidate genes will be screened according to their ex-
pression profiles, function, and possible involvement in
MO pathogenesis.
Recently, several association genetic studies reported
a possible association between different gene polymor-
phisms and either MA or MO. On the basis of these
studies, neurotransmitter receptors (Peroutka et al. 1997;
Del Zompo et al. 1998; Ogilvie et al. 1998; Lea et al.
2000), vasoconstrictor receptors, (Tzourio et al. 2001),
ion channel genes (May et al. 1995; Terwindt et al.
2001), and the INSR gene (McCarthy et al. 2001) can
be considered good candidates for migraine. Even if no
genes with such features were present within the chro-
mosomal region we have identified, there are some genes
that can be related to migraine pathogenesis. At present,
on the basis of their function and their expression pro-
files, probable candidate genes are the GTP cyclohydro-
lase 1 gene (GCH1 [MIM 600225]) and the atlastin gene
(SPG3A [MIM 606439]). Mutations in these genes have
been identified in Dopa-responsive dystonia (Ichinose et
al. 1994) and spastic paraparesis (Zhao et al. 2001), re-
spectively. Both of these genes are expressed in the CNS.
SPG3A encodes a peptide showing homology with sev-
eral GTPases that are involved in neurotransmission
(Zhao et al. 2001), whereas GCH1 encodes GTP cy-
clohydrolase I, which catalyzes the rate-limiting step of
tetrahydrobiopterin (Witter et al. 1996), cofactor of ty-
rosine and tryptophan hydroxylases, and nitric oxide
synthase (Werner et al. 1996). The latter three are in-
volved in the production of dopamine, serotonin, and
nitric oxide, which are implicated in migraine patho-
genesis (Hargreaves and Shepheard 1999). Moreover,
prostaglandin D2 receptor (PTGDR [MIM 606687])
and prostaglandin E receptor 2 genes (PTGER2 [MIM
176804]), which are implicated in inflammatory pro-
cesses and in pain responses (Funk et al. 2001), can
be considered candidate genes. The bone morphoge-
netic protein 4 gene (BMP4 [MIM 112262]) encodes
a cytokine belonging to the transforming growth fac-
tor-b superfamily and is implicated in the expression
of the neuropeptide calcitonin gene-related protein (Ai
et al. 1999), which mediates pain sensation and va-
sodilation (Goadsby et al. 1990).
In summary, we have identified an MO-susceptibility
locus on chromosomes 14q21.2–14q22.3. Further stud-
ies are required to identify the causative MO gene in
this family and to delineate the role of this locus in other
families affected with MO.
The detection of genes involved in MO will allow the
dissection of molecular mechanisms underlyingmigraine
attacks to aid in diagnosis and to develop rational ther-
apeutic tools.
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Figure 2 Multipoint localization of MO. Genetic location (distance in cM) is plotted against the multipoint LOD score. The locations
of markers used in the multipoint analysis are indicated. A maximum multipoint LOD score of 5.25 was obtained between markers D14S976
and D14S978.
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